-
Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing
Monday, August 7, 2017 - 11:55am | 1071Read More...The state of Ohio sues pharmaceutical companies for pushing painkillers. Missouri cops carry opioid antidotes in their cars. Judges everywhere play doctor, forcing abusers to choose between anti-addiction injections or jail. And the U.S. military — which has been dealing with opioid addiction...
-
States Are Firing Back At Opioid Drug Producers
Thursday, June 1, 2017 - 10:48am | 552Read More...The state of Ohio has filed a lawsuit against several top pharmaceutical companies, alleging that the companies violated the law in facilitating the spread of prescription opioid painkiller drugs that have contributed to a national opioid and heroin epidemic. Ohio Attorney General Mike DeWine...
-
How Much The Opioid Epidemic Actually Costs The Non-User
Sunday, May 28, 2017 - 3:15pm | 525Read More...It’s easy for the average American to dismiss the impact of the nation’s opioid abuse epidemic. However, heroin and prescription opioid painkiller addiction may be costing Americans much more than they realize. A recent study by the U.S. Surgeon General found that 27 million Americans...
-
Egalet Says FDA Saw Unintended Consequence Of IV Abuse Potential With Endo's Opana ER
Thursday, March 16, 2017 - 9:07am | 491Read More...The U.S. Food and Drug Administration reached a conclusion this week concerning Endo International plc - Ordinary Shares (NASDAQ: ENDP)'s therapy Opana ER, which is intended to treat pain severe enough to require a daily, around-the-clock, long-term opioid treatment. An independent FDA panel...
-
Exclusive: Egalet CEO Talks Drug Approvals, 21st Century Cures Act And Winning The War On Opioid Abuse
Thursday, January 19, 2017 - 9:37am | 1104Read More...Egalet Corp (NASDAQ: EGLT) was surely one of the most watched biotechs of the fourth quarter of 2016. After the company announced the Food and Drug Administration would miss its PDUFA decision date for Egalet’s opioid-based pain medication ARYMO ER, investors waited impatiently for news of a...
-
Could Chili Peppers Be The Answer To Opioid-Reliance For Chronic Pain?
Monday, June 27, 2016 - 1:50pm | 337Read More...Centrexion Therapeutics, led by former Pfizer Inc. (NYSE: PFE) Chief Executive Officer Jeffrey Kindler, is developing non-addictive painkillers with the help of chili peppers, according to a report on Bloomberg. One of the most common pain-management regimes in the United States is opiod-based drug...
-
Roddy Boyd Nailed Insys Therapeutics Thesis
Wednesday, April 13, 2016 - 2:02pm | 279Read More...Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged on Monday after the company provided preliminary first-quarter results. Insys Therapeutics, a specialty pharmaceutical company that develops supportive care products, announced that it expects its first-quarter revenue to fall in a range of $...








